Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Index investing lowers risk by reducing idiosyncratic bets and fees, delivering steadier, long-term growth. This intro explains the rationale and steps.
27,508 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
A 34% year-to-date drop has investors wondering if Zscaler can stage a comeback. This deep dive breaks down the catal...
BlackRock’s IBIT drew about $209 million in a single session, helping U.S. spot Bitcoin ETFs turn positive again. Mar...
Costco stock sits in the mid-700s as of July 2026. Analysts weigh whether a $2,000 target by 2030 is plausible, consi...
As Johnson & Johnson prepares July earnings, investors weigh the real case buying johnson thesis driven by durable in...
July 2026 market conditions put a premium on true readiness. This report outlines eight signs you’re financially read...
New screenshots and text exchanges are at the center of a high-stakes custody dispute. This article breaks down what ...
Microsoft leans on three strategic ties—OpenAI, hardware collaboration with AMD, and Copilot enterprise adoption—to s...
A top analyst argues that broad tariffs act like a dirty tax, risking higher debt costs as the U.S. grapples with a $...
Choosing when to claim Social Security isn’t just about age—it’s a strategy. Delaying benefits can lead to a larger l...
In February 2026, Beyond Meat shares surged roughly 24%, propelled by optimism around product expansion and earnings ...
New surveys in 2026 reveal mounting retirement worries: only about a quarter of Americans feel prepared, while the ty...